Chimeric Therapeutics is trading 6% up today at A$0.04 as the stock rebounds from recent selling pressure despite a lack of fresh corporate catalysts.

  • The move follows a steady decline from A$0.05 over prior sessions, which was largely attributed to profit-taking and cautious sentiment toward microcap biotech stocks.
  • Today’s bounce likely reflects bargain hunting and improved risk appetite rather than any fundamental changes or clinical developments.